129 related articles for article (PubMed ID: 2735930)
1. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts.
Horton JK; Thimmaiah KN; Houghton JA; Horowitz ME; Houghton PJ
Biochem Pharmacol; 1989 Jun; 38(11):1727-36. PubMed ID: 2735930
[TBL] [Abstract][Full Text] [Related]
2. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
Houghton JA; Williams LG; Torrance PM; Houghton PJ
Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
[TBL] [Abstract][Full Text] [Related]
3. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.
Houghton JA; Williams LG; Dodge RK; George SL; Hazelton BJ; Houghton PJ
Biochem Pharmacol; 1987 Jan; 36(1):81-8. PubMed ID: 3541941
[TBL] [Abstract][Full Text] [Related]
4. Modulation by verapamil of vincristine pharmacokinetics and sensitivity to metaphase arrest of the normal rat colon in organ culture.
Ince P; Elliott K; Appleton DR; Moorghen M; Finney KJ; Sunter JP; Harris AL; Watson AJ
Biochem Pharmacol; 1991 Apr; 41(8):1217-25. PubMed ID: 2009097
[TBL] [Abstract][Full Text] [Related]
5. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts.
Horton JK; Houghton PJ; Houghton JA
Biochem Pharmacol; 1988 Oct; 37(20):3995-4000. PubMed ID: 3190743
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
Horton JK; Houghton PJ; Houghton JA
Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
[TBL] [Abstract][Full Text] [Related]
7. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
8. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
[TBL] [Abstract][Full Text] [Related]
9. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.
Brewer F; Warr JR
Cancer Treat Rep; 1987 Apr; 71(4):353-9. PubMed ID: 2881620
[TBL] [Abstract][Full Text] [Related]
10. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma.
Song XR; Zheng Y; He G; Yang L; Luo YF; He ZY; Li SZ; Li JM; Yu S; Luo X; Hou SX; Wei YQ
J Pharm Sci; 2010 Dec; 99(12):4874-9. PubMed ID: 20821385
[TBL] [Abstract][Full Text] [Related]
11. Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Leuk Res; 1995 Nov; 19(11):823-9. PubMed ID: 8551799
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
Twentyman PR; Wright KA; Fox NE
Br J Cancer; 1990 Feb; 61(2):279-84. PubMed ID: 1968761
[TBL] [Abstract][Full Text] [Related]
13. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
Pérez V; Pierré A; Léonce S; Anstett M; Atassi G
Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
[TBL] [Abstract][Full Text] [Related]
14. Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration.
Houghton JA; Meyer WH; Houghton PJ
Cancer Treat Rep; 1987; 71(7-8):717-21. PubMed ID: 3607783
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
Naito M; Tsuruo T
Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
[TBL] [Abstract][Full Text] [Related]
17. Stability of vincristine complexes in cytosols derived from xenografts of human rhabdomyosarcoma and normal tissues of the mouse.
Houghton JA; Williams LG; Houghton PJ
Cancer Res; 1985 Aug; 45(8):3761-7. PubMed ID: 2990677
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
Sehested M; Jensen PB; Skovsgaard T; Bindslev N; Demant EJ; Friche E; Vindeløv L
Br J Cancer; 1989 Dec; 60(6):809-14. PubMed ID: 2605092
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
